Quantification of microbubble-induced sonothrombolysis in an ex vivo non-human primate model.

Journal of Thrombosis and Haemostasis : JTH
Monica T HindsSanjiv Kaul

Abstract

In vitro studies with ultrasound (US) and microbubbles (MB) have reported that sono-thrombolysis can be achieved at high peak rarefactional acoustic pressure amplitudes (PRAPAs) using 0.25 and 1.05 MHz US frequencies. The aim of the current study was to determine if these parameters work on an ex vivo physiological model of thrombosis. A thrombogenic device was placed in an ex vivo chronic arteriovenous shunt in juvenile baboons. Platelet accumulation was measured by dynamic imaging of the device and the 10 cm thrombus tail with 111 In-labeled platelets. After 15 minutes of thrombus formation, treatment with either low-dose recombinant tissue plasminogen activator (rtPA) or low-dose rtPA + MB+US was performed for 20 minutes. Four US settings at 0.25% duty cycle were used: 0.25 MHz at PRAPAs of 1.20 and 2.20 MPa, and 1.05 MHz at 1.75 and 4.75 MPa. Platelet accumulation was not inhibited by low-dose rtPA or MB with US alone. Platelet accumulation was significantly reduced with 0.25 MHz US at 2.20 PRAPA (P < .001) and with 1.05 MHz at 1.75 MPa and 4.75 MPa (P < .05) when used with MB and low-dose rtPA. Although this approach prevented platelet accumulation it did not cause thrombolysis on the device. rtPA + MB + US (0.25 and 1.05 ...Continue Reading

References

Nov 1, 1992·The Journal of Clinical Investigation·C W FrancisV J Marder
Oct 1, 1991·Circulation·M ArianiR J Siegel
May 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·U M MarzecL A Harker
Nov 1, 1985·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·S R HansonL A Harker
Jan 1, 1972·Journal of Medical Primatology·M E ToddE I Goldsmith
Nov 1, 1966·Journal of Applied Physiology·J W Hampton, C Matthews
Oct 1, 1993·The Journal of Clinical Investigation·S R HansonA Gruber
Feb 1, 1993·Catheterization and Cardiovascular Diagnosis·F PhilippeG Montalescot
May 1, 1993·Journal of the American College of Cardiology·D HarpazR S Meltzer
Jan 1, 1995·Ultrasound in Medicine & Biology·A M NilssonS B Olsson
Apr 1, 1997·Cardiovascular Surgery : Official Journal of the International Society for Cardiovascular Surgery·P N RiggsD P Penney
Mar 9, 1999·Journal of Vascular Surgery·S VaezyL Crum
Jan 7, 2003·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Tadamichi SakumaSanjiv Kaul
Aug 14, 2003·The American Journal of Cardiology·Mauricio G CohenLiliana R Grinfeld
Oct 7, 2004·Journal of the American College of Cardiology·Robert J SiegelCharles W Francis
Aug 1, 2006·Journal of the American College of Cardiology·Kiyoshi IidaRobert J Siegel
Apr 17, 2007·Ultrasound in Medicine & Biology·Adrian F ProkopRonald A Roy
Apr 2, 2008·Ultrasound in Medicine & Biology·Saurabh DattaChristy K Holland
Jul 7, 2012·Ultrasound in Medicine & Biology·Jonathan E LeemanJohn J Pacella
Apr 6, 2013·Arteriosclerosis, Thrombosis, and Vascular Biology·Jeffrey R CrosbyBrett P Monia
Mar 27, 2015·Thrombosis and Haemostasis·Azzdine Y AmmiSanjiv Kaul
Feb 1, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·Christina U LorentzErik I Tucker
Jul 6, 2019·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Brian MottSanjiv Kaul
Dec 10, 2019·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Mrinal YadavaSanjiv Kaul

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.